340B Sales Increased 17% to $124B in 2023, Drug Industry Consulting Firm Finds 

Analysts from IQVIA found that 340B wholesale acquisition cost sales increased by 17% from 2022 to 2023.
The 340B program continued to expand in 2023, exceeding $124 billion in wholesale acquisition cost (WAC) sales—up from $107 billion [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Hospital Groups Ask MedPAC to Oppose Part B Rate Cut

Jonathan Jaffery, chief health care officer for AAMC, said reduced Medicare reimbursement to 340B hospitals would “devastate an already fragile health care safety net.”
Groups representing hospitals that rely on the 340B program recently urged congressional advisers against recommending reduced Medicare reimbursement to 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Lobbying Continues Rapid Pace Including by Big Name Firms

Merck and Marshfield Clinic Health System have joined the growing list of organizations in the 340B Working Table.
The 340B drug discount program—and congressional activity associated with it—remained a hot topic for lobbyists in the first three months [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug Industry Vendor, Free-Market Legal Non-Profit Echo PhRMA’s Call for Appeals Court to Rehear Arkansas 340B Contract Pharmacy Case

Two groups filed amicus briefs asking for a full appeals court panel to rehear a case on Arkansas' 340B contract pharmacy access law.
A drug industry vendor and a conservative non-profit each urged a full federal appeals court to rehear a case on [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Providers Generally Supportive, PhRMA Pans Final 340B Dispute Resolution Rule

After HHS released the long-awaited final rule for resolving 340B administrative disputes, provider groups generally supported and PhRMA denounced the updated process.
Provider advocates celebrated—with some reservations—the recently issued final rule reshaping the Administrative Dispute Resolution (ADR) process for 340B stakeholders. On [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Key Senator Says 340B Overhaul May Clear Congress in End-of-Year Package

Sen. John Thune (R-S.D.) told hospital executives that 340B legislation could clear Congress as part of a broader healthcare package late this session.
Sen. John Thune (R-S.D.), who is spearheading a major bipartisan 340B reform package, told hospital executives Tuesday that 340B legislation [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

California Initiative Targeting Nation’s Largest HIV Provider Submits Enough Signatures to Qualify for Ballot

Protect Patients Now gained the signatures necessary to qualify for a California ballot initiative on Medicaid that appears focused on one 340B provider.
Supporters recently submitted enough signatures to qualify for the ballot a California ballot initiative that aims to codify the governor’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Virginia Legislature to Act This Week on Governor’s Amendment to 340B Contract Pharmacy Access Bill

Tracy Douglas, CEO of the Virginia Community Healthcare Association, said she hopes that the Virginia legislature rejects Gov. Glenn Youngkin's (R) changes to a 340B contract pharmacy access bill.
Virginia legislators will soon act on Gov. Glenn Youngkin’s (R) proposed amendment to a 340B contract pharmacy access bill when [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospitals Raise Concerns on Biden Drug Shortage Proposal

HHS recently released a proposal to address drug shortages with measures focused on both hospitals and drug manufacturers.
While the Biden administration’s proposal to address drug shortages does not exempt certain drug products from 340B pricing like the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Stakeholders Clash on Patient Definition, 340B Spending Requirements in Comments on Senate ‘Group of Six’ Draft Overhaul

Advocacy groups for providers and drugmakers had diverging views in their comments on a draft Senate 340B overhaul.
Stakeholders disagreed on whether Congress should codify a new 340B patient definition or restrict how providers use 340B savings, in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live